Management of Mild Obstructive Sleep Apnea

Diagnostic Confirmation and Severity Classification

The American Academy of Sleep Medicine recommends that treatment decisions for mild OSA be based on the presence of symptoms and cardiovascular/cerebrovascular comorbidities, with CPAP or mandibular advancement devices recommended for symptomatic patients or those with hypertension, heart disease, or stroke 1, 2, 3
The diagnosis and treatment indication depends critically on symptom presence, including excessive daytime sleepiness, witnessed apneas, gasping/choking at night, morning headaches, or nocturia 1
78% of patients with confirmed OSA deny common symptoms, so absence of reported symptoms does not exclude clinically significant disease 1

For symptomatic mild OSA, the American College of Physicians recommends initiating positive airway pressure therapy or mandibular advancement device, with CPAP/APAP as first-line treatment 4, 1
Mandibular advancement devices are offered as an alternative for patients who prefer them or experience CPAP adverse effects, with custom-made dual-block MADs showing the strongest evidence 4, 2
Educational and behavioral interventions are provided at initiation and throughout the first weeks with telemonitoring to optimize adherence 4, 5

The American Heart Association recommends high-intensity comprehensive lifestyle intervention, combining reduced-calorie diet, behavioral therapy, and exercise, producing ~8 kg weight loss at 6-12 months 3
Meal substitution programs are most effective, producing 11.6 kg weight loss and 4.1 kg/m² BMI reduction 3
Exercise/physical activity component is essential, producing 9.0 kg weight loss and 3.2 kg/m² BMI reduction 3
Weight loss reduces AHI by 8.5 events/hour on average, with magnitude correlating to weight loss achieved 3

The American Academy of Sleep Medicine recommends establishing systematic follow-up regardless of initial treatment decision, with monitoring of treatment adherence, objective outcomes, and tracking of residual AHI, Epworth Sleepiness Scale scores, blood pressure, and hours of nightly PAP use 5, 1
Repeat PSG indications include after ≥10% body weight loss, substantial weight gain with symptom return, insufficient clinical response to CPAP, or if surgical/dental treatment performed 1